ClinConnect ClinConnect Logo
Search / Trial NCT05635669

Optimized Acupuncture Treatment for Female Stress Urinary Incontinence

Launched by YIN PING · Nov 22, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is investigating the use of acupuncture to help women who experience stress urinary incontinence (SUI), which is when you accidentally leak urine during activities like laughing, coughing, or exercising. The researchers want to find the best combination of acupuncture points to use in treatment, hoping to provide helpful evidence for improving acupuncture methods for this condition.

To be eligible for this study, participants need to be women aged 40 to 75 who have mild to moderate stress urinary incontinence. They should not have other types of urinary incontinence or certain medical conditions that could interfere with the trial. If you join the study, you can expect to receive acupuncture treatments as part of the research, and you'll be contributing to a better understanding of how acupuncture can help manage this common issue. The trial is currently looking for participants, so it's a good opportunity to explore a new treatment option.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients with mild to moderate SUI mentioned in the diagnostic criteria above;
  • Aged 40~75 years;
  • Sign the informed consent.
  • Exclusion Criteria:
  • Other types of urinary incontinence (urgent, overflow or mixed).
  • History of urinary incontinence surgery or pelvic floor surgery;
  • Pelvic organ prolapse ≥ stage II;
  • Symptomatic urinary tract infection;
  • Residual urine volume \> 30 mL;
  • Maximum urinary flow rate \< 20ml/s.
  • Limitation of movement (walk and/or run and/or climb stairs);
  • Patients who have been using drugs that may affect bladder function or receiving SUI specialized treatment;
  • Severe cardiovascular, cerebral, liver, kidney and hematopoietic system disease, mental disorders, diabetes, multiple system atrophy, cauda equina neuropathy and spinal cord disease;
  • Pregnancy or lactation period.
  • With cardiac pacemaker, acupuncture phobia or metal allergies;

About Yin Ping

Yin Ping is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and ethical practices, Yin Ping collaborates with leading research institutions and healthcare professionals to design and implement clinical trials across various therapeutic areas. The organization prioritizes patient safety and data integrity, striving to contribute meaningful insights to the medical community while fostering a culture of transparency and collaboration in all its endeavors.

Locations

Shanghai, , China

Patients applied

DC

1 patients applied

Trial Officials

YUELAI CHEN

Principal Investigator

Shanghai University of Traditional Chinese Medicine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials